Table 1.
Clinical and metabolic characteristics of the study subjects with and without sleep apnea
| Characteristics |
Positive sleep apnea study
MAP index ≥ 0.50 |
Negative sleep apnea study
MAP index < 0.50 |
Pvalue |
|---|---|---|---|
| Patients, No. | 119 | 218 | |
| Age, year | 59.9±10. 4 | 55.5±11.1 | <0.001 |
| Gender | |||
| Male | 87 (73.1%) | 82 (37.6%) | <0.001 |
| Female | 32 (26.9%) | 136 (62.4%) | |
| Body mass index (kg/m2) | 30. 5 ± 6.6 | 26.6 ± 3.7 | <0.001 |
| Smoking | 11 (9.2%) | 32 (14.7%) | 0.174 |
| Opium addiction | 1 (0.8%) | 5 (2.3%) | 0.430 |
| Family history | 17 (14.3%) | 49 (22.5%) | 0.085 |
| Systolic blood pressure, mmHg | 139.7 ± 20.3 | 134.2 ± 18.4 | 0.012 |
| Diastolic blood pressure, mmHg | 83.2 ± 12.5 | 82.1 ± 12.1 | 0.420 |
| Subjects with hypertension | 71(59.7 %) | 108 (49.5 %) | 0.048 |
| Triglycerides, mg/dL | 208.1 ± 121.1 | 168.5 ± 99.3 | 0.003 |
| Total cholesterol, mg/dL | 186.2 ± 51.3 | 171.2 ± 52.8 | 0.012 |
| HDL-cholesterol, mg/dL | 38.7 ± 9.8 | 43.8 ±11.5 | <0.001 |
| Dyslipidemia | 102 (85.7%) | 163 (74.8%) | 0.026 |
| Fasting blood glucose, mg/dL | 118.4 ± 39.9 | 116.7 ± 69.1 | 0.811 |
| Hyperglycemia | 32 (26.9%) | 46 (21.1%) | 0.280 |
| Subjects with at least three of the following: hypertension, hyperglycemia, overweight high triglyceride and low HDL-cholesterol values | 80 (67.2%) | 106 (48.6%) | 0.001 |
Data are presented as the means ± SD or as numbers and percentages. HDL;high-density lipoprotein, MAP; multivariable apnea risk.